TEAD4, a member of the TEAD family of transcription factors, contains a conserved TEA domain that mediates specific DNA binding to MCAT (muscle- and heart-specific activating factor) sequences, thereby regulating the expression of target genes. This family, which includes TEAD1 through TEAD4, functions primarily by forming complexes with the transcriptional coactivators YAP and TAZ, a partnership that is central to the execution of the Hippo signaling pathway. Through this interaction, TEAD4 drives the transcription of genes involved in cell proliferation, differentiation, and organ development, with key downstream targets including cell cycle regulators such as Cyclin D1 and anti-apoptotic factors like BIRC5, which collectively promote cell survival and growth. TEAD4 is critically expressed in both embryonic and adult tissues, playing essential roles in trophoblast stem cell maintenance, placentation, and the homeostasis of muscle and cardiac tissues, while also influencing metabolic processes such as glucose uptake through the regulation of GLUT4. Dysregulation of TEAD4 function, whether through mutations that impair DNA binding or YAP/TAZ interaction, or through aberrant expression levels, has significant pathological implications; for instance, loss of function can lead to embryonic lethality in mouse models or impaired muscle regeneration, whereas overexpression is frequently observed in cancers such as gastric and ovarian carcinoma, where it drives tumor progression by enhancing YAP/TAZ-mediated transcription of oncogenic genes. Furthermore, defects in the Hippo pathway that fail to properly inhibit TEAD4 activity can result in pathological tissue hyperplasia or fibrosis, and specific TEAD4 abnormalities have been linked to pregnancy complications including fetal growth restriction and preeclampsia, underscoring its vital role in maintaining physiological balance across development and adult life.
Subcellular localization of TEAD4 (and its protein):
Gene Ontology (GO) terms for TEAD4:
| Interacting Gene | Interaction | Source/Score |
| Name |
|---|
| 4390 Hippo signaling pathway [PATH:hsa04390] |
| Name |
|---|
| Fatty acid, triacylglycerol, and ketone body metabolism |
| Gene Expression |
| Generic Transcription Pathway |
| Metabolism of lipids and lipoproteins |
| PPARA activates gene expression |
| Regulation of lipid metabolism by Peroxisome proliferator-activated receptor alpha (PPARalpha) |
| YAP1- and WWTR1 (TAZ)-stimulated gene expression |
| Disease | Score | NofPmids | NofSnps | Source |
| Down Syndrome | 0.00272435 | 1 | 0 | LHGDN |
| Retinopathy of Prematurity | 0.000271442 | 1 | 0 | BeFree |
| Cutaneous Melanoma | 0.000271442 | 1 | 3 | BeFree |
| Malignant neoplasm of stomach | 0.000271442 | 1 | 0 | BeFree |
| Cataplexy | 0.000271442 | 1 | 2 | BeFree |
| melanoma | 0.000271442 | 1 | 0 | BeFree |
| Stomach Carcinoma | 0.000271442 | 1 | 0 | BeFree |
No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong
Qilu Normal University · Genelibs Bioinformatics Lab
750 Shunhua Rd, Jinan
2F, Bldg F, University Science Park
Tel: 0531-88819269
Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.
Business Email
E-mail: [email protected]